Reproductive Technologies Inc

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1982

Legal Domicile

Phone

5108411858

Tax Period

2023-01-01 to 2023-12-31

Reproductive Technologies Inc, founded in 1982, is a community nonprofit that reported $2.5M in total revenue in fiscal year 2023. Revenue grew 16% year-over-year, indicating healthy expansion.

Mission

To provide services to all women and men who choose to create or expand their families through donor insemination and sperm storage. Provides education and resources on donor insemination and fertility options. To promote openness, our Donor Identity Release Program allows each child, at age eighteen, to learn the identity of his or her donor. To enhance social understanding and to inform industry practices, conducts research on the psychosocial implications of donor insemination.

Program Service Accomplishments

Program 1

Expenses: $926,329

Semen Sales: In 2023 we sold 993 vials from donors in our Identity-Release Program and 1036 vials were distributed to intended parents. 206 conceptions were reported and there were 158 live births.

Program 2

Expenses: $385,970

Health Education and Research: In 2023, 469 recipients (intended parents) registered with us and were provided with health education related to fertility and achieving pregnancy through donor...

Health Education and Research: In 2023, 469 recipients (intended parents) registered with us and were provided with health education related to fertility and achieving pregnancy through donor insemination. Outreach: Research on psycho-social outcomes in donor-conception resulted in one published peer-reviewed journal article (in Fertility and Sterility) in 2023. Our research presentation at the 2023 American Association of Reproductive Medicine conference was awarded best paper.

Program 3

Expenses: $231,583

Cryo Program: In 2023, we provided sperm processing and storage services to 73 Directed/Known Donors and 84 Client Depositors who stored 374 and 510 vials respectively.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $253,182

Program Service Revenue $1,070,680

Investment Income $1,588

Other Revenue $1,194,820

TOTAL REVENUE $2,520,270

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,299,378

Fundraising Expenses $0

Program Expenses $1,543,882

Other Expenses $1,151,224

TOTAL EXPENSES $2,450,602

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,520,270	$2,163,804	+0.2%
Expenses	$2,450,602	$2,137,943	+0.1%
Net Income	$69,668	$25,861	+1.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Alice Ruby	Executive Director	40.00		$188,700	$0	$188,700
Catherine Carranza-Stafford	N/A	40.00		$138,507	$0	$138,507
Kenya J Campbell	N/A	40.00		$111,076	$0	$111,076
Meredith A Lewis	N/A	40.00		$106,907	$0	$106,907
Mickye Adams MD	Treasurer	4.00	Director	$0	$0	$0
Nikki Black	Director	4.00	Director	$0	$0	$0
Jacob Donaldson	Director	4.00	Director	$0	$0	$0
Robert Vermeulen	Secretary	4.00	Officer Director	$0	$0	$0
Erica Breneman MD	Director	4.00	Director	$0	$0	$0
Tasha Wilson LCSW	Director	4.00	Director	$0	$0	$0
Josh Levinger	Director	4.00	Director	$0	$0	$0
Julie Harris PhD	President	4.00	Officer Director	$0	$0	$0
Alice Ruby	Executive Dir.	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$2,520,270	$2,450,602	$1,980,608	$69,668
2022	$2,163,804	$2,137,943	$2,087,940	$25,861
2021	$2,031,976	$2,153,656	$2,060,710	$-121,680
2020	$1,086,177	$1,351,540	$2,134,067	$-265,363
2019	$1,296,215	$1,449,718	$2,003,467	$-153,503
2018	$1,565,464	$1,300,036	$2,411,874	$265,428